Spelling suggestions: "subject:"proteolytic"" "subject:"proteolytica""
111 |
Antibody-mediated inhibition of proteases of African trypanosomes.Huson, Laura. 21 October 2013 (has links)
The protozoan parasites Trypanosoma congolense and T. vivax cause trypanosomosis in
cattle. The major lysosomal cysteine proteinase of T. congolense, congopain, may
contribute to pathogenesis of the disease, and antibody-mediated inhibition of this
enzyme may contribute to mechanisms of trypanotolerance. Oligopeptidase B, a
trypanosomal serine peptidase, is also a potential virulence factor in African
trypanosomes because it is released into the host circulation by dead or dying parasites,
where it retains catalytic activity due to the enzyme's insensitivity to serum protease
inhibitors. The vaccine potential of the catalytic domain of congopain, C2, and
oligopeptidase B complexed with 0'2-macroglobulin (0'2M) was evaluated by producing
antibodies in rabbits. Inhibition of congopain and oligopeptidase B activity by these
antibodies was assessed.
The oligopeptidase B open reading frame from T. congolense and T. vivax was cloned
and expressed in Escherichia coli, from which active recombinant enzymes were
purified. These recombinant enzymes exhibited trypsin-like specificity for peptide
substrates, cleaving on the carboxy side of basic amino acid residues such as arginine and
lysine. Enzymes were found to be optimally active between pH 8 and 10, optimally
stable at pH 6, and showed activation by reducing agents and sensitivity to ionic strength.
The enzymes showed typical oligopeptidase B-like inhibitor profiles, except that they
were not inhibited by thiol sensitive inhibitors such as iodoacetamide and Nethylmaleimide.
High yields of bovine and rabbit 0'2M were isolated by a three-step procedure of
fractionation by PEG 6000, and zinc chelate and Sephacryl S-300 HR chromatography.
Congopain, its catalytic domain C2, papain and cathepsin L all cleaved the bait region of
bovine 0'2M and became trapped inside the 0'2M molecule, where their activity against
large molecular weight substrates was inhibited. C2 could thus be complexed with 0'2M
directly or used to form C2-0'2M-oligopeptidaseB complexes for immunisation purposes.
iv
The catalytic domain of congopain, C2, was used to immunise rabbits either without
adjuvant, as a water-in-oil emulsion with Freund's adjuvant, or in a complex with either
bovine or rabbit U2M. Freund's adjuvant elicited the highest anti-C2 antibody response.
However, the greatest inhibition, 65%, of C2 activity against Z-Phe-Arg-AMC was
obtained with antibodies produced by rabbits receiving C2-U2Mcomplexes.
In a second study, C2 and oligopeptidase B were used to immunise rabbits , either in
alum, or complexed to bovine U2M. Anti-C2 antibody levels were highest in rabbits
immunised with the free proteins in alum, whereas anti-oligopeptidase B antibody levels
were comparable for each adjuvant system. Anti-oligopeptidase antibodies produced
with alum gave 100% inhibition of oligopeptidase B activity. In contrast, antibodies
produced against C2-u2M-oligopeptidase B complexes had little effect on oligopeptidase
B activity. However, these antibodies inhibited 55% of C2 activity. Alum was a slightly
less efficient adjuvant for C2 and 50% inhibition of C2 activity was observed.
It appeared that immunisation of rabbits with C2 complexed to U2M resulted in the
production of antibodies that were better able to neutralise the proteolytic activity of C2
and congopain in vitro than that with conventional adjuvants . The immunisation of C2
complexed to bovine u2-macroglobulin therefore has the potential to neutralise parasite
congopain in vivo, and may contribute to an anti-disease vaccine against African
trypanosomosis. Complexation of oligopeptidase B to u2M offers no benefit, since
antibodies produced against this complex are not able to inhibit the activity of
oligopeptidase B. Immunisation with oligopeptidase B in alum is sufficient to produce
efficient enzyme-inhibiting antibodies in the context of an anti-disease vaccine against
African trypanosomosis. / Thesis (Ph.D.)-University of KwaZulu-Natal, Pietermaritzburg, 2006.
|
112 |
Protease distribution in J774 macrophagesMcDowall, Jaclyn. January 2007 (has links)
Cathepsin, matrix metalloproteinase (MMP) enzyme and tissue inhibitor of MMP (TIMP) distribution in J774 mouse macrophages has not been comprehensively studied. The distribution and vesicle regulation, trafficking and release of these is important, possibly suggesting drug targets for the therapeutic regulation of inflammatory disease and phagosomal killing of pathogenic organisms in J774 and other macrophages. Percentage
immunofluorescence and ultrastructural enzyme and inhibitor distribution, together with LysoTracker (acidity) and lysosome-associated membrane proteins (LAMPs) colocalisation (both indicating late endosome or “lysosomal” association), western blot estimates of percentage processed- and unprocessed intracellular and secreted enzyme and inhibitor, and vesicle size was used to assign enzyme and inhibitor to “classical” vesicle types. Antibodies against TIMP-1 and TIMP-2 were raised and all antibodies characterised for this purpose.
Together these were used to assign cathepsins H, S, D, B and L to possible secretory vesicles (±20 nm, non-acidic, LAMPs-negative, containing precursor enzymes) and identify at least 6 other endosome-“lysosome-like” vesicles. Cathepsin H appears to be present in classical early endosomes (±100 nm, non-acidic, LAMPs-negative) and cathepsin S in late endosomes(±50 nm, acidic, LAMPs-positive) and possibly “lysosomal” (“hybrid” or digestive organelles) (±150-200 nm, acidic, LAMPs-positive). Both cathepsins H and S, however, seem only reliable markers if used together with additional markers. Cathepsin D appearsmainly associated with “lysosomal” (“hybrid” or digestive organelles) (±150-200 nm, acidic,
LAMPs-positive), possibly consisting of further subpopulations which requires furtherinvestigation e.g. labelling for LAMP-1 and LAMP-2 and cathepsin D. Cathepsins B and Lmay occur in late endosomes and/or hybrid organelles and “secretory lysosomes” containing cathepsins B, D and L may also exist (±30-50 nm, acidic, LAMPs-positive).
The distribution of MMP-9, TIMP-1 and -2 in vesicles (non-acidic, LAMP-2-negative) thatappear novel and distinct from late endosome-“lysosome” vesicles were also demonstrated.
In LPS-stimulated cells, the identity of the large (±450 nm), possible recycling endosomes (Rab11-positive, LAMPs-negative), containing colocalised MMP-9 and TIMP-1, needs investigation i.e., requires further verification with triple labelling and EM. Possible cell membrane and recycling endosome localisation of TIMP-2 needs confirmation with labelling
of non-permeabilised cells and labelling for MT1-MMP and proMMP-2, respectively. / Thesis (M.Sc.)-University of KwaZulu-Natal, Pietermaritzburg, 2007.
|
113 |
Proteolytic activity of avian strains of Pasteurella multocidaMatope, G. Unknown Date (has links)
No description available.
|
114 |
Molecular export and pilin assembly : TCP biogenesis in Vibrio cholerae / J.R. Iredell.Iredell, J. R. January 1997 (has links)
Corrigenda pasted onto front fly-leaf. / Bibliography: leaves 247-286. / xv, 286 leaves : ill. (some col.) ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / This thesis examines an aspect of the pathogenesis of a model extracellular enteric pathogen, the causative agent of human cholera. The export of TcpA (Toxin-Coregulated Pilus) and assembly of the TCP is explored as a paradigm of macromolecular export in Gram negative bacteria. TcpA is examined in detail in an attempt to define strictly conserved regions between species. The TCP of the emergent 0139 (Bengal) serotype is demonstrated to be of El Tor type. The possibily that proteases such as the soluble haemagglutinin (SHA) may have a detachase role centring on TCP dispersal/TcpA degradation is also discussed. / Thesis (Ph.D.)--University of Adelaide, Dept. of Microbiology, 1997
|
115 |
Regulation of EphA4 expression through the APC-mediated ubiquitin-proteasome pathway /Shen, Ying. January 2007 (has links)
Thesis (M.Phil.)--Hong Kong University of Science and Technology, 2007. / Includes bibliographical references (leaves 81-90). Also available in electronic version.
|
116 |
Proteolytic cleavage of FOXM1 by caspases /Deng, Meihong. January 2006 (has links)
Thesis (M. Med. Sc.)--University of Hong Kong, 2006.
|
117 |
Increased stability of class II MHC-peptide complexes in macrophages infected with mycobacterium avium and the examination of a novel role for cathepsin L in the innate immune response to Francisella Novicida infectionFlorence, William Clinton, January 2007 (has links)
Thesis (Ph. D.)--Ohio State University, 2007. / Title from first page of PDF file. Includes bibliographical references (p. 152-176).
|
118 |
Desenvolvimento de formulações tópicas contendo papaína para o tratamento de feridas / Development of topical formulations containing papain to wounds treatment.Helaine Carneiro Capucho 27 April 2007 (has links)
O presente trabalho avaliou, por medida de conteúdo protéico, análise eletroforética, por determinação da atividade proteolítica e verificação da estabilidade dessa atividade, matérias-primas papaína de dois fabricantes. Formulações géis de Carbopol® 940, Natrosol® 250 HHR e Pluronic® F127, contendo matéria-prima papaína a 1%, foram desenvolvidas e avaliadas quanto à estabilidade e a eficácia in vitro da atividade proteolítica. Os estudos de estabilidade foram conduzidos por medida da atividade proteolítica da papaína, utilizando a caseína como substrato, em amostras armazenadas sob diferentes condições de temperatura e umidade. A eficácia da ação proteolítica in vitro foi avaliada em gel de poliacrilamida, contendo gelatina como substrato. A matéria-prima do fabricante B apresentou maior conteúdo protéico e maior atividade proteolítica do que a matériaprima do fabricante A. Ambas matérias-primas demonstraram estabilidade da atividade funcional, quando armazenadas a 4°C, por um período de 6 meses. Quando armazenadas a 30°C/70%UR e a 40°C/70%UR, houve perda acentuada dessa atividade. A medida da atividade proteolítica das formulações, após 48 horas de sua preparação, mostrou que apenas 8% da atividade funcional total foi detectada. Este resultado pode indicar interação entre a papaína e os componentes das formulações, levando a uma perda da atividade proteolítica, ou uma redução da velocidade da reação enzimática. Os estudos da estabilidade da atividade funcional mostraram que ambas formulações foram estáveis, quando armazenadas a 4°C, por 6 meses. Entretanto, quando armazenadas a 30°C/70%UR e a 40°C/70%UR, foi observada rápida redução da atividade proteolítica, em função do tempo de armazenamento. A avaliação da atividade proteolítica das formulações em gel de poliacrilamida, adicionado de gelatina como substrato, após 6 horas de incubação a 37°C, demonstrou que a formulação gel de Carbopol® 940 foi a mais eficaz, até mesmo superior à formulação extemporânea de matéria-prima papaína 1%, em solução aquosa. Este resultado evidencia que esse polímero foi o mais adequado para veicular a papaína. Além disso, foi o que apresentou maior eficácia proteolítica no teste in vitro. Dessa forma, esta formulação poderá ser empregada para auxiliar o processo de cicatrização de feridas e queimaduras, nos diferentes níveis assistenciais de saúde, com garantia de eficácia, segurança e qualidade. / The present work evaluated by content of protein measurement, electrophoresis, proteolytic activity determination and verification of this activity stability, raw materials of papain obtained from two manufacturers. Gel formulations of Carbopol® 940, Natrosol® 250 HHR and Pluronic® F127, and containing 1% of papain, were developed and evaluated with regard to stability and in vitro efficacy of proteolytic activity. The stability studies were conducted by papain proteolytic activity measurement, using casein as substrate and the samples were stored under different conditions of temperature and humidity. The in vitro efficacy of proteolytic activity was evaluated using polyacrylamide gel containing gelatin as substrate. The raw material obtained from manufacturer B showed higher content of protein and higher proteolytic activity than the one from manufacturer A. Both raw materials showed functional stability when stored at 4°C during 6 months. When stored at 30°C/70% RH and at 40°C/70% RH, there was significant loss of these activities. The measure of formulations proteolytic activity, after 48 hours from its preparation, showed that only 8% of the total activity was detected. This result might indicate possible interactions between papain and formulation components, which lead to a loss in the proteolytic activity or a reduction in the speed of enzymatic reaction. The functional stability studies showed that all formulations were stable when stored at 4°C during 6 months. However, when stored at 30°C/70%RH and 40°C/70%RH, it was observed fast decrease in the proteolytic activity as a function of storage time. The evaluation of formulations proteolytic activity in polyacrylamide gel, added with gelatin as substrate, after 6 hours of incubation at 37°C, showed that Carbopol® 940 gel formulation was the most efficient, being also better than the formulation recently prepared with 1% of papain raw material in aqueous solution. This result demonstrates that this polymer was the most adequate to be incorporated with papain. Besides this, it was the one that showed higher proteolytic efficacy in the in vitro test. Then, this formulation might be employed to help in the wound and burns cicatrisation process, in the different levels of health assistance, with efficacy, security and quality guarantee.
|
119 |
Structural analysis of prodomain inhibition of cysteine proteases in plasmodium speciesNjuguna, Joyce Njoki January 2012 (has links)
Plasmodium is a genus of parasites causing malaria, a virulent protozoan infection in humans resulting in over a million deaths annually. Treatment of malaria is increasingly limited by parasite resistance to available drugs. Hence, there is a need to identify new drug targets and authenticate antimalarial compounds that act on these targets. A relatively new therapeutic approach targets proteolytic enzymes responsible for parasite‟s invasion, rupture and hemoglobin degradation at the erythrocytic stage of infection. Cysteine proteases (CPs) are essential for these crucial roles in the intraerythrocytic parasite. CPs are a diverse group of enzymes subdivided into clans and further subdivided into families. Our interest is in Clan CA, papain family C1 proteases, whose members play numerous roles in human and parasitic metabolism. These proteases are produced as zymogens having an N-terminal extension known as the prodomain which regulates the protease activity by selectively inhibiting its active site, preventing substrate access. A Clan CA protease Falcipain-2 (FP-2) of Plasmodium falciparum is a validated drug target but little is known of its orthologs in other malarial Plasmodium species. This study uses various structural bioinformatics approaches to characterise the prodomain‟s regulatory effect in FP-2 and its orthologs in Plasmodium species (P. vivax, P. berghei, P. knowlesi, P. ovale, P. chabaudi and P. yoelii). This was in an effort to discover short peptides with essential residues to mimic the prodomain‟s inhibition of these proteases, as potential peptidomimetic therapeutic agents. Residues in the prodomain region that spans over the active site are most likely to interact with the subsite residues inhibiting the protease. Sequence analysis revealed conservation of residues in this region of Plasmodium proteases that differed significantly in human proteases. Further prediction of the 3D structure of these proteases by homology modelling allowed visualisation of these interactions revealing differences between parasite and human proteases which will lead to significant contribution in structure based malarial inhibitor design.
|
120 |
SphereZyme (TM) technology for enhanced enzyme immobilisation application in biosensorsMolawa, Letshego Gloria January 2011 (has links)
Self-immobilisation enzyme technologies, such as SphereZyme™, suffer from the lack of applicability to hydrolyse large substrates. Solid support immobilisation is usually a method of choice, to produce a stable biocatalyst for large substrates hydrolysis in the industry. In order to investigate this limitation, a commercial protease called Alcalase® was chosen as a model enzyme due to its natural activity (hydrolysis of large substrates-proteins). Prior to immobilising through the SphereZyme™ technology, Alcalase® was partially purified through dialysis followed by CM Sepharose™ FF cation exchanger. Sample contaminants, such as salts and stabilisers can inhibit protein crosslinking by reacting with glutaraldehyde. Alcalase® was successfully separated into 3 proteases with the major peak correlating to a positive control run on native PAGE, indicating that it was likely subtilisin Carlsberg. A 16% alkaline protease activity for azo-casein hydrolysis was retained when 5% v/v PEI: 25% v/v glutaraldehyde solution was used as a crosslinking agent in Alcalase® SphereZyme™ production. An increase in activity was also observed for monomeric substrates (PNPA) where the highest was 55%. The highest % activities maintained when 0.33 M EDA: 25% v/v glutaraldehyde solution was initially used as crosslinking agent were 4.5% and 1.6% for monomeric and polymeric substrates, respectively. PEI is a hydrophilic branched polymer with an abundance of amine groups compared to EDA. A comparison study of immobilisation efficiencies of SphereZyme™, Eupergit® and Dendrispheres was also performed for large substrate biocatalysis. The two latter technologies are solid-support immobilisation methods. Dendrispheres reached its maximum loading capacity in the first 5 minute of the one hour binding time. Twenty minutes was chosen as a maximum binding time since there was constant protein maintained on the solid support and no enzyme loss was observed during the 1 hour binding time. PEI at pH 11.5, its native pH, gave the highest immobilisation yield and specific activity over the PEI pH range of 11.5 to 7. SphereZyme™ had the highest ratio for azocasein hydrolysis followed by Dendrispheres and Eupergit®. The SphereZyme™ was also shown to be applicable to biosensors for phenol detection. Different modifications of glassy carbon electrode (GCE) were evaluated as a benchmark for the fabrication of SphereZyme™ modified phenol biosensor. GCE modified with laccase SphereZyme™ entrapped in cellulose membrane was the best modification due to the broad catechol range (<0.950 mM), high correlation coefficient (R2, 0.995) and relative high sensitivity factor (0.305 μA.mM-1). This type of biosensor was also shown to be electroactive at pH 7.0 for which its control, free laccase, lacked electroactivity. From the catalytic constants calculated, GCE modified with laccase SphereZyme™ entrapped in cellulose membrane also gave the highest effectiveness factor (Imax/Km app) of 1.84 μA.mM-1. The modified GCE with Alcalase® SphereZyme™ was relatively more sensitive than GCE modified with free Alcalase®.
|
Page generated in 0.0302 seconds